Stock FLGT FULGENT GENETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
20.3 USD -2.07% Intraday chart for Fulgent Genetics, Inc. -1.69% -29.78%
May. 03 Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024
May. 03 Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating
MT
UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating
MT
UBS Initiates Coverage on Fulgent Genetics With Neutral Rating, $35 Price Target
MT
Fulgent Genetics Swings to Loss in Q2, Revenue Declines; Raises Guidance; Shares Surge 10% Pre-Bell
MT
Credit Suisse Lowers Fulgent Genetics' Price Target to $45 From $50 After Mixed Q4 Results, Keeps Outperform Rating
MT
Piper Sandler Downgrades Fulgent Genetics to Neutral From Overweight, Adjusts Price Target to $40 From $65
MT
Raymond James Starts Fulgent Genetics at Outperform With $45 Price Target
MT
Piper Sandler Adjusts Price Target on Fulgent Genetics to $65 From $70, Maintains Overweight Rating
MT
Credit Suisse Adjusts Fulgent Genetics' Price Target to $50 From $65, Keeps Outperform Rating
MT
Credit Suisse Initiates Fulgent Genetics at Outperform with $65 Price Target
MT
Piper Sandler Adjusts Fulgent Genetics' Price Target to $70 From $85, Reiterates Overweight Rating
MT
Oppenheimer Adjusts Fulgent Genetics Price Target to $112 From $123, Maintains Outperform Rating
MT
Piper Sandler Adjusts Fulgent Genetics' Price Target to $85 From $80, Reiterates Overweight Rating
MT
Oppenheimer Adjusts Fulgent Genetics Price Target to $123 From $125, Maintains Outperform Rating
MT
Piper Sandler Assumes Fulgent Genetics at Overweight with $80 Price Target
MT
Oppenheimer Adjusts Fulgent Genetics' Price Target to $125 From $141, Maintains Outperform Rating
MT
FULGENT GENETICS : Credit Suisse Adjusts Fulgent Genetics' Price Target to $65 from $55, Keeps Underperform Rating
MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $141 From $118, Maintains Outperform Rating
MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $118 From $126, Maintains Outperform Rating
MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $126 From $130 on Q1 Preview, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FLGT Stock
  4. News Fulgent Genetics, Inc.
  5. Analyst Reco.